CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Phase 1/2, dose escalation and expansion study designed to evaluate the safety and tolerability of NVL-655, determine the recommended phase 2 dose (R...
Clinical trials
Research sites
Resources
Legal